In the present study, three glycolysis genes (ELF3, AURKA, and ADH7) were significantly related to survival and were used to construct a risk signature that showed high accuracy in predicting the overall survival (OS) of HNSCC. This evidence concerns the gene ADH7 and head and neck squamous cell carcinoma.